June 5 - 9, 2015, Boston, Massachusetts
Results of Major Cardiovascular Trials to be Reported at the Scientific Sessions
Two major cardiovascular trials will be unveiled at the 75th Scientific Sessions. These studies, ELIXA and TECOS, examine two different incretin drugs and both include heart failure as a major cardiovascular outcome.
Marc Pfeffer, MD, PhD, Victor J. Dzau Professor of Medicine at Harvard Medical and principal investigator for the ELIXA trial will chair the symposium, The Evaluation of Lixisenatide in Acute Coronary Syndrome—The Results of ELIXA, on Monday, June 8, from 2:15 p.m. to 4:15 p.m. The ELIXA executive committee will discuss initial results of the trial in 6,000 patients with type 2 diabetes who experienced an acute coronary event. The trial compares a once-daily dose of lixisenatide to placebo with cardiovascular events as the primary endpoint.
This will be followed by Results from the Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin (TECOS) from 4:30 p.m. to 6:30 p.m. Principal investigator Rury Holman, MB, ChB, Professor of Diabetic Medicine and Director of the University of Oxford Diabetes Trial Unit, will lead the TECOS symposium. TECOS is the third major trial of dipeptidyl-peptidase-4 inhibitors with nearly 15,000 participants and the longest patient follow up. The two earlier trials, SAVOR-TIMI 53 and EXAMINE, showed an overall neutral effect on cardiovascular outcomes.
Scientific Sessions App Now Available
Make the most of your time at the meeting with the 75th Scientific Sessions App. Features include a customizable calendar and itinerary builder, interactive meeting program and session schedules, exhibitor listing with interactive booth map, social media interface, and more!
m.core-apps.com/tristar_ada15 on your desktop or mobile device. You can also download the App on Google Play, the App Store, or scan the QR code below.
Online Itinerary Planner Now Available
The online Itinerary Planner
is now available! View the entire program in a user-friendly format and create a personalized itinerary for the sessions you would like to attend in Boston.
Registration and Housing
Registration is still open. Visit our Registration page to register for the meeting.
Housing is now closed! Please contact the hotel directly if you need to make any changes or cancellations.
Please Note: Abstract bodies will be made available online at 5 p.m. EDT on Friday, May 29, 2015. Prior to that date and time, only abstract titles will be available.
S-C-I-E-N-C-E Spells Progress
To accelerate scientific innovation and to celebrate our 75th Anniversary, the American Diabetes Association is launching a fundraising campaign to raise $75 million exclusively for research at the Association’s 75th Scientific Sessions. In recognition of your work and that of your colleagues, please help us start a chain reaction of giving. Your gift will benefit the Association’s Research Foundation and Pathway to Stop Diabetes Research Initiative. Look for special displays at the meeting and for more information in the coming months. To support these efforts today, go to diabetes.org/progress
Join us for the first annual Scientific Sessions Walking Challenge, supported by AstraZeneca. We’re challenging participants to take 75,000 steps over the days of the event to commemorate our 75 years of service to those affected by diabetes.
The first 1,000 attendees to register and pick up a wireless activity tracker will compete to see who takes the most steps!
Scientific Sessions eNewsletters
to receive the latest information and updates on the 75th Scientific Sessions.
Film Screening—Journey to a Miracle: Freedom from Insulin
Journey to a Miracle: Freedom from Insulin is the story of dedicated scientists and the grateful families they helped. In the film, families share the devastating diagnosis of what doctors only knew to call type 1 diabetes. Thanks to critical research advances, these individuals now share a new diagnosis of monogenic diabetes and with it the appropriate medical therapy.
The American Diabetes Association funded the development of the first registry for people with monogenic diabetes by Dr. Louis Philipson at the University of Chicago. The stories documented in this film offer clear demonstration of the critical importance of research—to understand the underpinnings of disease in order to bring transformational treatments to people with diabetes. The film will be shown on Saturday from Noon to 1:00 p.m., and from 12:30 p.m. to 1:30 p.m. on Sunday and Monday in Room 204 of the Boston Convention and Exhibition Center.
Highlights of the 74th Scientific Sessions
Peer Reviewed Highlights from the 2014 Scientific Sessions—MD Conference Express
The highlights of the meeting are written from primary sources and are peer-reviewed to ensure that the advances in diabetes care are reported with accuracy and balance. The publication is a valuable resource and has proven to be an enduring reference of the meeting. View
the MD Conference Express e-book.